Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × tucatinib × 30 days × Clear all

Phase

Status

Recruiting 5 Not yet recruiting 2 Active not recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 21 pembrolizumab 18 Cisplatin 17 Gemcitabine 15 Nivolumab 14 Paclitaxel 11 Dexamethasone 11 fludarabine 10 Blood Specimen Collection 10 palbociclib 8 Radiotherapy 8 Lenalidomide 8 Exercise 8 Carboplatin 8 Bortezomib 8 Rituximab 7 Docetaxel 7 Biopsy 6 durvalumab 5 atezolizumab 5 Vincristine 5 Trastuzumab 5 Tamoxifen 5 Specimen Handling 5 Prednisone 5 Oxaliplatin 5 Letrozole 5 Irinotecan 5 Ipilimumab 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04539938 2026-03-23

HER2CLIMB-04

Seagen Inc.

Phase 2 Completed

70 enrolled 23 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡